Metabolic-Fit / 100
Tablet Health review
A multi-vertical telehealth platform offering both injectable ($199/mo semaglutide, $299/mo tirzepatide) and a cheaper oral option for each molecule — a genuinely uncommon needle-free path — but with ambiguous FDA-adjacent marketing language, inconsistent self-reported customer counts, and no published state list.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Tablet Health at a glance
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- Does not disclose a specific state list
- Brand-name
- Compounded only
How we scored Tablet Health
Every factor comes from Tablet Health's own published pricing, disclosures and oversight, and the six combine into the 40/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.tablethealth.com/telehealth
$199 for semaglutide and $299 for tirzepatide, with LegitScript certification and physical pharmacy locations opening in New York — real oversight signals beyond a pure direct-to-consumer funnel. Its marketing elsewhere blurs 'FDA-registered labs' with FDA-approved medication, an overstatement worth recognizing. No state list is disclosed.
What to expect when you sign up
We walked Tablet Health's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action leaves tablethealth.com for try.tablethealth.com, a separate host
What we noticed
- A monthly price is visible on the public homepage before any intake — you do not have to hand over information to see a number
- Intake is hosted on try.tablethealth.com, so the company you fill the form in with is not the domain you started on
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $199 | InjectableA cheaper oral option is also sold, starting at $179/mo — genuinely uncommon in this category. |
| Compounded tirzepatide | $299 | InjectableA cheaper oral option is also sold, starting at $199/mo. |
| Oral semaglutide | $179 | Oral |
| Oral tirzepatide | $199 | Oral |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Tablet Health's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Genuine oral option for both semaglutide and tirzepatide, priced lower than the injectable
- LegitScript Certified
- Opening physical pharmacy locations in NYC — an oversight signal beyond a pure DTC funnel
- No commitment, cancel anytime, stated plainly
The caveats
- Marketing copy elsewhere blurs 'FDA-registered labs' with FDA-approved medication — a real overstatement pattern
- Self-reported customer counts are inconsistent across the site (15,000+ vs. 10,000+)
- No specific state list published — its own FAQ leaves the question unanswered
- No postpartum, breastfeeding or PCOS-specific guidance found
Tablet Health for mothers: our verdict
A multi-vertical telehealth platform offering both injectable ($199/mo semaglutide, $299/mo tirzepatide) and a cheaper oral option for each molecule — a genuinely uncommon needle-free path — but with ambiguous FDA-adjacent marketing language, inconsistent self-reported customer counts, and no published state list. It runs about $199/month.
We weigh Tablet Health the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What Tablet Health costs, in full
- Compounded semaglutide — Injectable: $199/mo
- Compounded tirzepatide — Injectable: $299/mo
- Oral semaglutide — Oral: $179/mo
- Oral tirzepatide — Oral: $199/mo
That lands within a few dollars of the ~$179/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
On that last point Tablet Health is no help: it doesn't break down what the monthly figure covers — whether the provider visit, shipping and any lab work are inside it or billed separately. Ask before you pay, because that answer is what decides whether a mid-range price is actually mid-range.
The medications Tablet Health prescribes
Tablet Health prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where Tablet Health fits — and where it doesn't — for mothers
A good fit if…
- you want a real clinician reading your history around postpartum and breastfeeding timing, not an auto-approving quiz.
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Tablet Health is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers who specifically want a needle-free oral GLP-1 option and are comfortable calling ahead to confirm their state.
Alternatives to Tablet Health
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Tablet Health
Head-to-head & alternatives
Tablet Health, answered
- How much does Tablet Health cost?
- Injectable compounded semaglutide starts at $199/mo and injectable tirzepatide at $299/mo. Both are also sold as an oral option — $179/mo and $199/mo respectively — a genuinely uncommon needle-free path in this category.
- Does Tablet Health serve my state?
- It doesn't say. The site's own FAQ asks 'What states do you ship to?' and leaves the answer blank — call and confirm before you sign up.
- Is Tablet Health's GLP-1 medication FDA-approved?
- No — like most compounded programs, it isn't. Some of Tablet Health's own marketing copy ('Clinically-proven,' 'FDA-registered labs') blurs an FDA-registered facility with an FDA-approved drug. Read that as ordinary compounding-industry overstatement, not a claim the medication itself is approved.
Pricing, states and verification reflect Tablet Health's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.